- Home
- Publications
- Publication Search
- Publication Details
Title
Adenosine in cancer immunotherapy: Taking off on a new plane
Authors
Keywords
-
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume -, Issue -, Pages 189005
Publisher
Elsevier BV
Online
2023-11-01
DOI
10.1016/j.bbcan.2023.189005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer
- (2022) Alberto A. Chiappori et al. CLINICAL CANCER RESEARCH
- COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non–Small-Cell Lung Cancer
- (2022) Roy S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
- (2022) Emerson A. Lim et al. CLINICAL CANCER RESEARCH
- Safety and efficacy of the anti-CD73 monoclonal antibody (mAb) oleclumab ± durvalumab in patients (pts) with advanced colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), or EGFR-mutant non-small cell lung cancer (EGFRm NSCLC).
- (2021) Johanna C. Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints
- (2021) Elham Baghbani et al. LIFE SCIENCES
- Immunotherapy takes aim at exhausted T cells
- (2020) Elie Dolgin NATURE BIOTECHNOLOGY
- CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
- (2020) Miao Yu et al. Nature Communications
- On the mechanism of anti-CD39 immune checkpoint therapy
- (2020) David Allard et al. Journal for ImmunoTherapy of Cancer
- Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
- (2020) Sharmilla Devi Jayasingam et al. Frontiers in Oncology
- A phase I, open-label, multicenter study to assess the safety, pharmacokinetics, and preliminary antitumor activity of AZD4635 both as monotherapy and in combination in patients with advanced solid malignancies: Results from prostate cancer patients (NCT02740985).
- (2020) Emerson A. Lim et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting CD73 to augment cancer immunotherapy
- (2020) Meejeon Roh et al. CURRENT OPINION IN PHARMACOLOGY
- Adenosine A2A Receptor Antagonists for Cancer Immunotherapy
- (2020) Fazhi Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of AB680: A Potent and Selective Inhibitor of CD73
- (2020) Kenneth V. Lawson et al. JOURNAL OF MEDICINAL CHEMISTRY
- The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity
- (2020) Alexandra Borodovsky et al. Journal for ImmunoTherapy of Cancer
- Purine Release, Metabolism, and Signaling in the Inflammatory Response
- (2019) Joel Linden et al. Annual Review of Immunology
- Immunobiology, preliminary safety, and efficacy of CPI-006, an anti-CD73 antibody with immune modulating activity, in a phase 1 trial in advanced cancers.
- (2019) Jason J. Luke et al. JOURNAL OF CLINICAL ONCOLOGY
- CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
- (2019) Xiao-Lu Ma et al. Journal of Hematology & Oncology
- Adenosine Interaction with Adenosine Receptor A2a Promotes Gastric Cancer Metastasis by Enhancing PI3K–AKT–mTOR Signaling
- (2019) Linsen Shi et al. MOLECULAR BIOLOGY OF THE CELL
- Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
- (2019) Lawrence Fong et al. Cancer Discovery
- Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells
- (2019) Beatris Mastelic-Gavillet et al. Journal for ImmunoTherapy of Cancer
- Adenosine Metabolism: Emerging Concepts for Cancer Therapy
- (2019) Detlev Boison et al. CANCER CELL
- CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment
- (2019) Shi Yong Neo et al. JOURNAL OF CLINICAL INVESTIGATION
- OUP accepted manuscript
- (2018) Briefings in Functional Genomics
- Canonical and non-canonical adenosinergic pathways
- (2018) E. Ferretti et al. IMMUNOLOGY LETTERS
- Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction
- (2018) Lijun Jia et al. LIFE SCIENCES
- Purinergic Regulation of Neutrophil Function
- (2018) Xu Wang et al. Frontiers in Immunology
- Abstract LB-291: EOS100850, an insurmountable and non-brain penetrant A2Areceptor antagonist, inhibits adenosine-mediated T cell suppression, demonstrates anti-tumor activity and exhibits best-in class characteristics
- (2018) Erica Houthuys et al. CANCER RESEARCH
- The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1
- (2018) Marthe Koussémou et al. PLoS One
- A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
- (2018) Stephen B. Willingham et al. Cancer Immunology Research
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
- (2017) Mohammad H. Kazemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Endotoxin-induced autocrine ATP signaling inhibits neutrophil chemotaxis through enhancing myosin light chain phosphorylation
- (2017) Xu Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adenosine reduces reactive oxygen species and interleukin-8 production by Trichomonas vaginalis-stimulated neutrophils
- (2017) Amanda Piccoli Frasson et al. Purinergic Signalling
- Cancer associated fibroblasts: An essential role in the tumor microenvironment
- (2017) Leilei Tao et al. Oncology Letters
- The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway
- (2017) Yihong Zhou et al. Oncotarget
- Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455
- (2017) Stefania Gessi et al. Frontiers in Pharmacology
- A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
- (2017) Melanie Mediavilla-Varela et al. NEOPLASIA
- CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
- (2017) Jieyao Li et al. OncoImmunology
- The SLC28 (CNT) and SLC29 (ENT) nucleoside transporter families: a 30-year collaborative odyssey
- (2016) J. D. Young BIOCHEMICAL SOCIETY TRANSACTIONS
- Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
- (2016) Arabella Young et al. CANCER CELL
- Abstract 2337: The adenosine A2A receptor antagonist CPI-444 blocks adenosine-mediated T-cell suppression and exhibits antitumor activity alone and in combination with anti-PD-1 and anti-PD-L1
- (2016) Stephen Willingham et al. CANCER RESEARCH
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
- (2016) Philippe Gascard et al. GENES & DEVELOPMENT
- Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action
- (2016) James C. Geoghegan et al. mAbs
- Emerging concepts of T cell metabolism as a target of immunotherapy
- (2016) Chih-Hao Chang et al. NATURE IMMUNOLOGY
- Medicinal chemistry of adenosine, P2Y and P2X receptors
- (2016) Kenneth A. Jacobson et al. NEUROPHARMACOLOGY
- Equilibrative nucleoside transporters—A review
- (2016) Rebba C. Boswell-Casteel et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression
- (2016) Claudia Sorrentino et al. Oncotarget
- A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
- (2016) Akio Ohta Frontiers in Immunology
- CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
- (2015) Martin Turcotte et al. CANCER RESEARCH
- CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression
- (2015) María Rosa Bono et al. FEBS LETTERS
- CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells
- (2015) Felipe Flores-Santibáñez et al. IMMUNOLOGY
- IFN-γ Prevents Adenosine Receptor (A2bR) Upregulation To Sustain the Macrophage Activation Response
- (2015) Heather B. Cohen et al. JOURNAL OF IMMUNOLOGY
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model
- (2015) Claudia Sorrentino et al. Oncotarget
- NAD+-Metabolizing Ectoenzymes in Remodeling Tumor–Host Interactions: The Human Myeloma Model
- (2015) Alberto Horenstein et al. Cells
- A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
- (2015) Robert D. Leone et al. Computational and Structural Biotechnology Journal
- Vascular CD39/ENTPD1 Directly Promotes Tumor Cell Growth by Scavenging Extracellular Adenosine Triphosphate
- (2015) Lili Feng et al. NEOPLASIA
- Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
- (2015) Raffaella Iannone et al. NEOPLASIA
- Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
- (2014) C. Cekic et al. CANCER RESEARCH
- Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
- (2014) C. Cekic et al. CANCER RESEARCH
- Adenosine A2A Receptor Antagonists in Parkinson’s Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued
- (2014) Annalisa Pinna CNS DRUGS
- NT5E and FcGBP as key regulators of TGF-1-induced epithelial–mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer
- (2013) Li Xiong et al. CELL AND TISSUE RESEARCH
- Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
- (2013) B. Allard et al. CLINICAL CANCER RESEARCH
- The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling
- (2013) Christopher James Ferrante et al. INFLAMMATION
- Pannexin 1 Channels Link Chemoattractant Receptor Signaling to Local Excitation and Global Inhibition Responses at the Front and Back of Polarized Neutrophils
- (2013) Yi Bao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Extracellular adenosine regulates naive T cell development and peripheral maintenance
- (2013) Caglar Cekic et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells
- (2013) M. G. Terp et al. JOURNAL OF IMMUNOLOGY
- IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39
- (2013) Ivan D Mascanfroni et al. NATURE IMMUNOLOGY
- The role of purinergic pathways in the pathophysiology of gut diseases: Pharmacological modulation and potential therapeutic applications
- (2013) Luca Antonioli et al. PHARMACOLOGY & THERAPEUTICS
- Blockade of A2Areceptors potently suppresses the metastasis of CD73+tumors
- (2013) Paul A. Beavis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Adenosine-Mediated Signaling Pathway Suppresses Prenylation of the GTPase Rap1B and Promotes Cell Scattering
- (2013) E. Ntantie et al. Science Signaling
- A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
- (2013) Alberto L Horenstein et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Regulation of Neutrophil Function by Adenosine
- (2012) Kathryn E. Barletta et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer inCd39/Entpd1null Mice
- (2012) Xiaofeng Sun et al. HEPATOLOGY
- Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer
- (2012) Xiuling Zhi et al. IUBMB LIFE
- CD73 represses pro-inflammatory responses in human endothelial cells
- (2012) Jana KG Gr�newald et al. Journal of Inflammation-London
- Purinergic Signaling during Inflammation
- (2012) Holger K. Eltzschig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5′-Nucleotidase
- (2012) Rafael Fernandes Zanin et al. PLoS One
- Adora2b Adenosine Receptor Engagement Enhances Regulatory T Cell Abundance during Endotoxin-Induced Pulmonary Inflammation
- (2012) Heidi Ehrentraut et al. PLoS One
- The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
- (2012) Akio Ohta et al. Frontiers in Immunology
- CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
- (2011) S. Serra et al. BLOOD
- CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
- (2011) J. Stagg et al. CANCER RESEARCH
- Adenosine promotes alternative macrophage activation via A2A and A2B receptors
- (2011) Balázs Csóka et al. FASEB JOURNAL
- Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
- (2011) S. Ryzhov et al. JOURNAL OF IMMUNOLOGY
- A Role for the Low-Affinity A2B Adenosine Receptor in Regulating Superoxide Generation by Murine Neutrophils
- (2011) D. van der Hoeven et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
- (2011) Beat M. Künzli et al. Purinergic Signalling
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
- (2010) Xiaofeng Sun et al. GASTROENTEROLOGY
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia
- (2009) Meixiang Yang et al. IMMUNOLOGY AND CELL BIOLOGY
- Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+Regulatory T Cells
- (2009) Magis Mandapathil et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
- (2009) Michail V. Sitkovsky TRENDS IN IMMUNOLOGY
- Adenosine receptors in regulation of dendritic cell differentiation and function
- (2008) S. V. Novitskiy et al. BLOOD
- Central role of Sp1-regulated CD39 in hypoxia/ischemia protection
- (2008) H. K. Eltzschig et al. BLOOD
- Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function
- (2008) Balázs Csóka et al. FASEB JOURNAL
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
- (2008) György Haskó et al. NATURE REVIEWS DRUG DISCOVERY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started